U.S. Markets open in 8 hrs 20 mins

Harrow Health, Inc. (HROW)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.43+0.56 (+5.67%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.87
Open10.18
Bid0.00 x 2200
Ask0.00 x 800
Day's Range10.11 - 10.72
52 Week Range4.65 - 11.24
Volume631,160
Avg. Volume242,781
Market Cap277.252M
Beta (5Y Monthly)0.91
PE Ratio (TTM)27.89
EPS (TTM)0.37
Earnings DateAug 09, 2021 - Aug 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.00
  • Harrow (HROW) Surges 12%: Is This an Indication of Further Gains?
    Zacks

    Harrow (HROW) Surges 12%: Is This an Indication of Further Gains?

    Harrow (HROW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

  • Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
    GlobeNewswire

    Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

    NASHVILLE, Tenn., June 17, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the closing of its underwritten registered public offering of $20 million aggregate principal amount of 8.625% senior notes due 2026 (the “Notes”), which includes the full exercise of the over-allotment option of $2.5 million aggregate principal amount granted to the underwriters. The Notes will be treated as a single

  • Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
    GlobeNewswire

    Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

    NASHVILLE, Tenn., June 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the pricing of its underwritten registered public offering of $17.5 million aggregate principal amount of 8.625% senior notes due 2026 (the “Notes”). The Company has granted the underwriters a 30-day option to purchase an additional $2.5 million aggregate principal amount of Notes in connection with the offering. The